Monday, March 27, 2023

Aadi Bioscience Adds Board Member

Los Angeles-based biopharmaceuticals company Aadi Bioscience announced this morning that it has added Mohammad Hirmand, M.D., to its board of directors. Hirmand was most recently Executive Vice President and Chief Medical Officer for Turning Point Therapeutics (acquired by Bristol Myers Squibb in August of 2022). Aadi Bioscience says Dr. Hirmand has more than 20 years of biotechnology clinical development experience.